To support the health, safety, and well-being of organizations, their employees, and the individuals they serve or care for by helping to promote, monitor, and improve hand hygiene compliance ultimately saving thousands of lives and billions of dollars in unnecessary expense
In May 2022, the WHO published its first ever global report on infection prevention and control (add reference footnote) in which it stated that 70% of global infections could be prevented where good hand hygiene practices were followed. Additionally, Infection transmission leading to significant mortalities has been a major issue for years yet has flown under the radar, however, the Covid pandemic has shone a spotlight on the importance of implementing a proven solution to proper hand hygiene.
Frontline workers and care givers are also putting their own health at risk. The awareness of the importance of hand washing has grown tremendously while institutional reputations are in jeopardy. Forward-looking companies will seek out opportunities to invest in, partner with, or acquire technologies to improve the overall health and wellbeing of their organizations and the communities they serve.
“Validation Zones” are established using an ultrasound-based transmitter to trigger audible, time-based reminders when it's time to wash hands, or if appropriate hand hygiene does not occur.
Individuals wear a wireless ID tag which records all hand hygiene events when moving in and out of “Validation Zones.” Data is collected and transmitted directly to the system’s data server in real-time.
The system features a sensor in the dispenser (soap, alcohol, etc.) to specifyand validate who, when, and where hands were sanitized.
Since 2010, well in advance of the COVID 19 pandemic, HanGenix has been at the forefront of helping healthcare institutions confront the problem of hand hygiene negligence. The vulnerabilities of poor hand hygiene are not limited to hospitals, they remain critical issues in all medical practices, long-term care facilities, and any industry where there is considerable person-to-person or person-to-surface contact.
The recurring revenue opportunity for implementation of the Hangenix System in U.S. hospitals alone is between
$1-2 billion annually.
Leveraging the HanGenix® technology beyond the healthcare industry – food service, restaurants, food processing, hospitality, clean rooms, education, and more – expands the global recurring revenue potential into the
tens of billions of dollars.
Dental Practices
Restaurants
Food Processing
Long-Term Care
Hospitality
Airlines
Banking
Education
Fast Food
HanGenix’ technology is protected through exclusive, global rights to 3 issued patents(US8164439, US821653, US8547220) with a broadly written claim based on using ultrasound as ameans to validate compliance to protocols and transmit unique data.
$300-500K in bridge funding on a convertible note offering. Minimum investment of $25K
Global Health Impact Fund: $1.5M globalhealthimpactfund.com Founders/Angels: $950K
Complete 2 confirmed nursing home pilots and support operations over a 6 month period
PILOT REFERENCES AVAILABLE UPON REQUEST
Chief Executive Officer
Jeff is a results-driven leader, with a proven track record of exceeding goals, profitable revenue growth, strategy development and execution, as well as team leadership. Jeff’s considerable experience in sales and sales management, product development, marketing and strategy, and operations consulting is the ideal background needed now to drive the HanGenix commercialization process.
Chief Technology Officer
Garrett comes from a computer science and finance background. He got his start in management consulting in the area of pricing strategy and big data analytics, leading the development of customized software. He advanced to the private equity space, leading value realization efforts for a software startup specializing in enterprise revenue management. Before transitioning to Hangenix, Garrett led the research, analytics, and pricing group for a national marketing organization.
Chief Medical Officer
With more than 25 years of experience in both internal and emergency medicine, Dr. Waters will direct the clinical technology enhancements. Dr. Waters earned his undergraduate degree from Brown University, his medical degree from Temple University School of Medicine, and his Juris Doctorate from Rutgers University Law School. He is both board certified in internal medicine and a non-practicing attorney, bringing diverse experience and expertise to the HanGenix leadership team.
Board Chairman,
Partner and “Growth Coach” at Healthcare IT Leaders
CEO, HanGenix
Principal and Managing Director,
Global Health Impact Fund
Previous Operating Partner,
Bessemer Venture Partners
Infectious Disease Advisor
Co-Inventor, previous CEO of Radianse, MIT Faculty
Senior VP/GM Strategic Corporate Accounts, Siemens
Founder and Managing Partner, Global HealthImpact Fund
Surgeon and Investor
Clinical Advisor
CEO, Healthcare Technology Strategist
Vice Chair, Quality Improvement, Department of Anesthesiology, Emory University School of Medicine
Marketing Communications Advisors
Co-Inventor, Harvard PHD and professor, and strategic advisor at Mass General
Managing Partner, Catalysta Partners, LLC.
I will personally get back to you within 48 hours – Jeff Kline
Phone: 770-315-6320
Email: jeff.kline@hangenixsolutions.com